Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Venous Thromboembolism Treatment Market

Venous Thromboembolism Treatment Market Share

  • Report ID: GMI3929
  • Published Date: Apr 2021
  • Report Format: PDF

Venous Thromboembolism Treatment Market Share

Leading companies are undertaking the several venous thromboembolism treatment market expansion strategies such as:

  • Boston Scientific Corporation
  • AngioDynamics

  •  Cardinal Health

  • Covidien

  • Daesung Maref

  • Cook Medical

  •  Argon Medical Products

 of new treatment systems and acquisition of firms to fortify their portfolio and market position.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The revenue share of the venous thromboembolism treatment industry was valued at USD 950 million in 2020 and will rise at a CAGR of over 8.7% up to 2027 with a higher prevalence of cardiovascular diseases (CVD) and cancer.

The market size from the compression system device segment reached USD 120 million in 2020 and will grow with increasing adoption across DVT prophylaxis.

The market revenue from pulmonary embolism applications is expected to observe a growth rate of 9.4% up to 2027 due to the increasing prevalence of the disease.

Hospitals accounted for over 75% of total revenue share in 2020 and will see higher expansion owing to the increase in the number of surgical procedures that require VTE prophylactic devices.

North America was responsible for over 40% of the venous thromboembolism treatment revenue share in 2020 due to the rise in the number of initiatives in the region.

Venous Thromboembolism Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2020
  • Companies covered: 7
  • Tables & Figures: 192
  • Countries covered: 18
  • Pages: 120
 Download Free Sample